629 related articles for article (PubMed ID: 28396946)
1. Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes.
Amer R; Alsughayyar W; Almeida D
Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1423-1432. PubMed ID: 28396946
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of Behçet's disease in the Indian population.
Sachdev N; Kapali N; Singh R; Gupta V; Gupta A
Int Ophthalmol; 2009 Dec; 29(6):495-501. PubMed ID: 18936879
[TBL] [Abstract][Full Text] [Related]
3. [Clinical features of patients with Behcet's uveitis].
Liu XS; Gao F; Zhao C; Zhang MF
Zhonghua Yan Ke Za Zhi; 2020 Mar; 56(3):217-223. PubMed ID: 32187951
[No Abstract] [Full Text] [Related]
4. Behçet's disease ocular attack score 24 and visual outcome in patients with Behçet's disease.
Tanaka R; Murata H; Takamoto M; Ohtomo K; Okinaga K; Yoshida A; Kawashima H; Nakahara H; Fujino Y; Kaburaki T
Br J Ophthalmol; 2016 Jul; 100(7):990-994. PubMed ID: 26553921
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience.
Sota J; Cantarini L; Vitale A; Sgheri A; Gentileschi S; Caggiano V; Gelardi V; Frediani B; Tosi GM; Fabiani C
Mediators Inflamm; 2020; 2020():6872402. PubMed ID: 32508524
[TBL] [Abstract][Full Text] [Related]
6. Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population.
Pathanapitoon K; Kunavisarut P; Saravuttikul FA; Rothova A
Ocul Immunol Inflamm; 2019; 27(1):2-6. PubMed ID: 29020486
[TBL] [Abstract][Full Text] [Related]
7. Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa.
Khairallah M; Attia S; Yahia SB; Jenzeri S; Ghrissi R; Jelliti B; Zaouali S; Messaoud R
Int Ophthalmol; 2009 Jun; 29(3):135-41. PubMed ID: 18365145
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
Zlatanović G; Jovanović S; Veselinović D; Zivković M
Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
[TBL] [Abstract][Full Text] [Related]
9. Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.
Interlandi E; Leccese P; Olivieri I; Latanza L
Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S58-62. PubMed ID: 25005224
[TBL] [Abstract][Full Text] [Related]
10. [Association between optical coherence tomography findings and visual acuity of Behcet's disease-associated uveitis patients during remission stage].
Zhou W; Yang Z; Liu X; Han X; Zhang M
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):746-9. PubMed ID: 26693769
[TBL] [Abstract][Full Text] [Related]
11. Behcet's disease with uveitis in Taiwan.
Chung YM; Lin YC; Tsai CC; Huang DF
J Chin Med Assoc; 2008 Oct; 71(10):509-16. PubMed ID: 18955185
[TBL] [Abstract][Full Text] [Related]
12. Ocular Manifestations, Conventional Fundus Fluorescein Angiographic Findings, and Relationship Between Angiographic Findings and Visual Acuity in Behçet's Disease.
Bazvand F; Zarei M; Ebrahimiadib N; Karkhaneh R; Davoudi S; Soleimanzadeh M; Sharifian E; Roohipoor R; Modjtahedi BS
Semin Ophthalmol; 2017; 32(6):764-771. PubMed ID: 27715380
[TBL] [Abstract][Full Text] [Related]
13. Pars plana vitrectomy for ocular complications of Behçet's disease.
Sullu Y; Alotaiby H; Beden U; Erkan D
Ophthalmic Surg Lasers Imaging; 2005; 36(4):292-7. PubMed ID: 16156145
[TBL] [Abstract][Full Text] [Related]
14. Ocular Manifestations in Late Onset Behçet's Disease.
Saadouli D; Mansour KB; Yahyaoui S; Afrit NE; Lahmar A; Afrit AE
Curr Aging Sci; 2021; 14(1):56-61. PubMed ID: 31994475
[TBL] [Abstract][Full Text] [Related]
15. [Ocular manifestations in Behçet's disease].
Zeghidi H; Saadoun D; Bodaghi B
Rev Med Interne; 2014 Feb; 35(2):97-102. PubMed ID: 24290834
[TBL] [Abstract][Full Text] [Related]
16. Uveitis in Behçet disease: an analysis of 880 patients.
Tugal-Tutkun I; Onal S; Altan-Yaycioglu R; Huseyin Altunbas H; Urgancioglu M
Am J Ophthalmol; 2004 Sep; 138(3):373-80. PubMed ID: 15364218
[TBL] [Abstract][Full Text] [Related]
17. [Ocular manifestations in Behçet's disease].
Desbois AC; Terrada C; Cacoub P; Bodaghi B; Saadoun D
Rev Med Interne; 2018 Sep; 39(9):738-745. PubMed ID: 29625716
[TBL] [Abstract][Full Text] [Related]
18. Clinical profile and management with immunosuppressants and biologics in Behcet's uveitis: A cohort of 25 patients from a tertiary eye care center in South India.
Ramdoss J; Singh P; Ahmed AS; Biswas J
Indian J Ophthalmol; 2023 May; 71(5):1972-1976. PubMed ID: 37203067
[TBL] [Abstract][Full Text] [Related]
19. Multifocal choroiditis with panuveitis incidence of ocular complications and of loss of visual acuity.
Thorne JE; Wittenberg S; Jabs DA; Peters GB; Reed TL; Kedhar SR; Dunn JP
Ophthalmology; 2006 Dec; 113(12):2310-6. PubMed ID: 16996607
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors of ocular involvement in Behçet's disease].
Belkhadir K; Boutimzine N; Laghmari M; Amazouzi A; Tachfouti S; Cherkaoui O
J Fr Ophtalmol; 2019 Jun; 42(6):612-617. PubMed ID: 31088739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
